Human Immunoglobulin (China biologic products)

人免疫球蛋白（泰邦生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Immunoglobulin (China biologic products)
Drug Alias NameIntravenous immunoglobulin (China Biologic Products)Immunoglobulin intravenous 5% (China Biologic Products)Human immunoglobulin 5% (China Biologic Products)Immunoglobulin intravenous 10% (China Biologic Products)
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrticariaDermatitis, Allergic ContactThrombocytopenia +[5] 
Global Approved IndicationsUrticariaDermatitis, Allergic ContactAsthma
Approved Indications in ChinaUrticariaDermatitis, Allergic ContactAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaibang Biotech (Shandong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Taibang Biological Products Co LtdGuizhou Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsUrticariaDermatitis, Allergic ContactThrombocytopenia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksWikipediaDrugBankKEGG